Armstrong, SC (2004). Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovascular Research 61(3), 427–436.
Calcagni, G, Adorisio, R, Martinelli, S, Grutter, G, Baban, A, Versacci, P, Digilio, MC, Drago, F, Gelb, BD, Tartaglia, M and Marino, B (2018). Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies. Heart Failure Clinics 14(2), 225–235.
Desvignes, J-P, Bartoli, M, Delague, V, Krahn, M, Miltgen, M, Béroud, C and Salgado, D (2018). VarAFT: a variant annotation and filtration system for human next generation sequencing data. Nucleic Acids Research 46(Web Server issue), W545–W553.
Dhillon, AS, Pollock, C, Steen, H, Shaw, PE, Mischak, H and Kolch, W (2002). Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Molecular and Cellular Biology 22(10), 3237–3246.
Ezquieta, B, Santomé, JL, Carcavilla, A, Guillén-Navarro, E, Pérez-Aytés, A, del Pozo J, Sánchez, García-Miñaur, S, Castillo, E, Alonso, M, Vendrell, T, Santana, A, Maroto, E and Galbis, L (2012). Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy. Revista Espanola De Cardiologia (English Ed.) 65(5), 447–455.
Gelb, BD, Roberts, AE and Tartaglia, M (2015). Cardiomyopathies in Noonan syndrome and the other RASopathies. Progress in Pediatric Cardiology 39(1), 13–19.
Hakami, F, Dillon, MW, Lebo, M and Mason-Suares, H (2016). Retrospective study of prenatal ultrasound findings in newborns with a Noonan spectrum disorder: prenatal diagnosis of Noonan spectrum disorders. Prenatal Diagnosis 36(5), 418–423.
Hickey, EJ, Mehta, R, Elmi, M, Asoh, K, McCrindle, BW, Williams, WG, Manlhiot, C and Benson, L (2011). Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. Congenital Heart Disease 6(1), 41–47.
Hopper, RK, Feinstein, JA, Manning, MA, Benitz, W and Hudgins, L (2015). Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutation. American Journal of Medical Genetics. Part A 167A(4), 882–885.
Ko, JM, Kim, J-M, Kim, G-H and Yoo, H-W (2008). PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome. Journal of Human Genetics 53(11–12), 999–1006.
Kobayashi, T, Aoki, Y, Niihori, T, Cavé, H, Verloes, A, Okamoto, N, Kawame, H, Fujiwara, I, Takada, F, Ohata, T, Sakazume, S, Ando, T, Nakagawa, N, Lapunzina, P, Meneses, AG, Gillessen-Kaesbach, G, Wieczorek, D, Kurosawa, K, Mizuno, S, Ohashi, H, David, A, Philip, N, Guliyeva, A, Narumi, Y, Kure, S, Tsuchiya, S and Matsubara, Y (2010). Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation. Human Mutation 31(3), 284–294.
Kuburović, V, Vukomanović, V, Carcavilla, A, Ezquieta-Zubicaray, B and Kuburović, N (2011). Two cases of LEOPARD syndrome--RAF1 mutations firstly described in children. The Turkish Journal of Pediatrics 53(6), 687–691.
Lee, BH, Kim, J-M, Jin, HY, Kim, G-H, Choi, J-H and Yoo, H-W (2011). Spectrum of mutations in Noonan syndrome and their correlation with phenotypes. The Journal of Pediatrics 159(6), 1029–1035.
Limongelli, G, Hawkes, L, Calabro, R, McKenna, WJ and Syrris, P (2006). Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy. European Journal of Medical Genetics 49(5), 426–430.
Nystrom, AM, Ekvall, S, Berglund, E, Björkqvist, M, Braathen, G, Duchen, K, Enell, H, Holmberg, E, Holmlund, U, Olsson-Engman, M, Annerén, G and Bondeson, M (2008). Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders. Journal of Medical Genetics 45(8), 500–506.
Pandit, B, Sarkozy, A, Pennacchio, LA, Carta, C, Oishi, K, Martinelli, S, Pogna, EA, Schackwitz, W, Ustaszewska, A, Landstrom, A, Bos, JM, Ommen, SR, Esposito, G, Lepri, F, Faul, C, Mundel, P, López Siguero, JP, Tenconi, R, Selicorni, A, Rossi, C, Mazzanti, L, Torrente, I, Marino, B, Digilio, MC, Zampino, G, Ackerman, MJ, Dallapiccola, B, Tartaglia, M and Gelb, BD (2007). Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nature Genetics 39(8), 1007–1012.
Prendiville, TW, Gauvreau, K, Tworog-Dube, E, Patkin, L, Kucherlapati, RS, Roberts, AE and Lacro, RV (2014). Cardiovascular disease in Noonan syndrome. Archives of Disease in Childhood 99(7), 629–634.
Razzaque, MA, Nishizawa, T, Komoike, Y, Yagi, H, Furutani, M, Amo, R, Kamisago, M, Momma, K, Katayama, H, Nakagawa, M, Fujiwara, Y, Matsushima, M, Mizuno, K, Tokuyama, M, Hirota, H, Muneuchi, J, Higashinakagawa, T and Matsuoka, R (2007). Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nature Genetics 39(8), 1013–1017.
Rohini, A, Agrawal, N, Koyani, CN and Singh, R (2010). Molecular targets and regulators of cardiac hypertrophy. Pharmacological Research 61(4), 269–280.
Sala, V, Gallo, S, Leo, C, Gatti, S, Gelb, BD and Crepaldi, T (2012). Signaling to cardiac hypertrophy: insights from human and mouse RASopathies. Molecular Medicine 18(1), 938–947.
Sana, ME, Spitaleri, A, Spiliotopoulos, D, Pezzoli, L, Preda, L, Musco, G, Ferrazzi, P and Iascone, M (2014). Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome. American Journal of Medical Genetics. Part A 164A(8), 2069–2073.
Tartaglia, M, Gelb, BD and Zenker, M (2011). Noonan syndrome and clinically related disorders. Best Practice & Research Clinical Endocrinology & Metabolism 25(1), 161–179.
Thompson, D, Patrick-Esteve, J, Surcouf, JW, Rivera, D, Castellanos, B, Desai, P, Lilje, C, Lacassie, Y, Marble, M and Zambrano, R (2017). RAF1 variants causing biventricular hypertrophic cardiomyopathy in two preterm infants: further phenotypic delineation and review of literature. Clinical Dysmorphology 26(4), 195–199.
Tumurkhuu, M, Saitoh, M, Sato, A, Takahashi, K, Mimaki, M, Takita, J, Takeshita, K, Hama, T, Oka, A and Mizuguchi, M (2010). Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway: genetic analysis in RAS pathway syndromes. Pediatrics International 52(4), 557–562.
Wilkinson, JD, Lowe, AM, Salbert, BA, Sleeper, LA, Colan, SD, Cox, GF, Towbin, JA, Connuck, DM, Messere, JE and Lipshultz, SE (2012). Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. American Heart Journal 164(3), 442–448.